|
|
| (11) | Number of the document | C 3660033 |
| (68) | Number of the document | 3660033 |
| (21) | Application number for Supplementary Protection Certificate | PA 2022 010 |
| (22) | Date of filing the application | 2022-05-31 |
| (41) | Date of publication of the application | 2022-06-27 |
| Date of publication of SPC | 2025-02-25 | |
| (24) | Date of coming into effect of SPC | 2033-11-16 |
| (71) |
Apellis Pharmaceuticals, Inc. ,
100 5th Avenue, Waltham, MA 02451,
US
|
| (73) |
Apellis Pharmaceuticals, Inc. ,
100 5th Avenue, Waltham, MA 02451,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/21/1595, 2021-12-13 |
| (94) | 2036-12-14 |
| (95) | Pegcetacoplanas |
| SPC granted |